Clinical Trial Update: Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the impact of cladribine tablets on central nervous system biomarkers in individuals with multiple sclerosis, including…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Cladribine tablets (cladribine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting | Phase 4 | Status: COMPLETED